APA (7th ed.) Citation

Tisseur, L., Logé, C., Cojean, S., Gassama, K., Karcher, L., Pagniez, F., . . . Marchand, P. (2025). Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy. RSC medicinal chemistry.

Chicago Style (17th ed.) Citation

Tisseur, Lhana, et al. Pharmacophore-guided Optimization of the Hit Compound CTN1122 in the Design of Promising Imidazo[1,2-]pyrazine Derivatives Targeting the Casein Kinase 1 for Antileishmanial Therapy. RSC medicinal chemistry, 2025.

MLA (9th ed.) Citation

Tisseur, Lhana, et al. Pharmacophore-guided Optimization of the Hit Compound CTN1122 in the Design of Promising Imidazo[1,2-]pyrazine Derivatives Targeting the Casein Kinase 1 for Antileishmanial Therapy. RSC medicinal chemistry, 2025.